Kidney Cancer
Prostate Cancer
EAU Edu Platform on Bladder Cancer
Home
Articles
Article of the Month
Editorial
Videos
Webcasts
Education
Curriculum NMIBC
E-courses
Webinars
ESOU Online
Clinical problems
Guidelines
Events
Home
Articles
Terug
Article of the Month
Editorial
Videos
Webcasts
Education
Terug
Curriculum NMIBC
E-courses
Webinars
ESOU Online
Clinical problems
Guidelines
Events
Upcoming event
Masterclass on Non-muscle-invasive bladder cancer
Home
/
muscle-invasive bladder cancer
Back
Tag:
muscle-invasive bladder cancer
Perioperative durvalumab with or without tremelimumab plus neoadjuvant enfortumab vedotin in muscle-invasive bladder cancer: results from the Phase 3 VOLGA trial
View
Perioperative pembrolizumab or placebo plus neoadjuvant cisplatin and gemcitabine in participants with muscle-invasive bladder cancer who are eligible for cisplatin: the double-blind, phase III KEYNOTE-866 study
View
Can FAP PET guide future theranostic approaches in bladder cancer? Insights from Dr. Laukhtina at EMUC 2026
View
EV-303, EV-304 and VOLGA: Prof. Powles on redefining perioperative treatment for muscle-invasive bladder cancer at EMUC 2026
View
Results from a phase 3 trial of neoadjuvant chemotherapy alone vs in combination with nivolumab followed by postsurgical adjuvant nivolumab in patients with muscle-invasive bladder cancer
View
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
I agree
Read More